Memorial Sloan Kettering Cancer Center

This is your central portal for breaking news, the latest research and important updates from Memorial Sloan Kettering Cancer Center. Bookmark this page and check back often for updates.

Cover Story

Pancreatic cancer — a changing outlook if diagnosed early

HemOnc Today, January 10, 2020
Tumor DNA sequencing to identify appropriate targeted therapies is revolutionizing treatment of a variety of cancers, and pancreatic cancer — a…
FDA News

FDA panel narrowly supports approval of maintenance olaparib in BRCA-mutated pancreatic cancer

December 17, 2019
An FDA panel today supported approval of olaparib as maintenance treatment for adults with deleterious or suspected deleterious germline…

GO2 Foundation presents Young Innovators Team Awards for lung cancer research

December 6, 2019
GO2 Foundation for Lung Cancer announced the recipients of its 2019 Young Innovators Team Awards. The awards are designed to encourage creative…
Meeting News

Major developments in multiple myeloma to be presented at ASH

December 2, 2019
Starting Saturday, December 7, HemOnc Today will be onsite in Orlando at the ASH Annual Meeting and Exposition, bringing the latest in important…
Cover Story

Financial disclosure in oncology leaves ‘room for standardization’

HemOnc Today, November 25, 2019
Reporting of financial ties to industry has become an increasingly contentious, ethically murky area in both oncologic research and clinical…
Meeting News

Tipifarnib induces responses in HRAS-mutant head and neck squamous cell carcinoma

November 15, 2019
Tipifarnib induced durable objective responses among patients with metastatic or recurrent head and neck squamous cell carcinoma with HRAS
Meeting News

Novel bispecific immune cell engager safe, clinically beneficial in HER2-positive tumors

November 10, 2019
NATIONAL HARBOR, Md. — An investigational bispecific T-cell engager appeared safe and demonstrated some clinical activity among patients with…
In the JournalsPerspective

Trifluridine and tipiracil safe, effective for pretreated metastatic gastric cancer regardless of prior gastrectomy

November 7, 2019
Trifluridine and tipiracil significantly extended PFS and OS compared with placebo among patients with previously treated metastatic gastric or…
In the Journals

New treatment approaches induce responses in unresectable intrahepatic cholangiocarcinoma

November 6, 2019
Chemotherapy combined with hepatic arterial infusion of floxuridine or with selective internal radiotherapy induced antitumor activity among patients…
Cover Story

Depression in oncologists: For many, a closely guarded secret

HemOnc Today, October 25, 2019
Oncologists, and physicians in general, are trained to strive for excellence, remain strong and resilient in the most difficult circumstances, and…
Cover Story

Developing a Pause Button for CAR T-Cell Therapy

Cell Therapy Next, October/November 2019
Chimeric antigen receptor T-cell therapy has proven to be a life-changing development for those with advanced, treatment refractory leukemia and…
Meeting NewsPerspective

Targeted therapy shows benefit in advanced cholangiocarcinoma

October 1, 2019
BARCELONA, Spain — Ivosidenib improved outcomes among patients with isocitrate dehydrogenase-mutated advanced cholangiocarcinoma, according to…
Meeting News

Memorial Sloan Kettering Cancer Center oncologist receives lifetime achievement award

September 15, 2019
Charles Rudin, MD, PhD, received the Paul A. Bunn Jr. Scientific Award from International Association for the Study of Lung Cancer. The award…
Meeting News

Speaker: Rationale exists to test CAR T-cell therapy in KRAS-mutated lung cancer

September 11, 2019
BARCELONA — Enriched cell surface expression of mesothelin in
Cover Story

Making lifestyle changes ‘part of the cancer treatment conversation’

HemOnc Today, September 10, 2019
Approximately 42% of cancer cases are linked to modifiable risk factors that are well-known to the general public, according to the American Cancer…
Meeting NewsPerspective

Selpercatinib induces deep, durable responses in RET fusion-positive lung cancer

September 10, 2019
BARCELONA — The investigational drug selpercatinib induced deep antitumor responses among patients with RET fusion-positive non-small cell…

Samuel Waxman Cancer Research Foundation awards $1.4 million in grants

September 5, 2019
The Samuel Waxman Cancer Research Foundation awarded $1.4 million worth of new grants to fund investigations into multiple scientific areas. The…

‘Visibility matters’ when establishing LGBTI-friendly practice for younger patients with cancer

August 28, 2019
It was at the height of Australia’s marriage equality debate in 2017 when Kate Thompson, MSW, approached her colleague — social worker…
In the Journals

Teratoma linked to higher cumulative incidence of germ cell tumor-related death

August 16, 2019
Teratoma appeared associated with a higher cumulative incidence of disease-related death among men with nonseminomatous germ cell primary tumors…
In the Journals

Abdominal radiation dose linked to diabetes risk among childhood cancer survivors

August 2, 2019
Higher pancreatic tail radiation doses during childhood cancer treatment appeared associated with higher risk for diabetes later in life, according…